Related Experiment Video

Updated: May 26, 2026

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

Recurrent parotitis as a presentation of primary pediatric Sjögren syndrome

Kevin Baszis1, Dana Toib, Megan Cooper

  • 1Division of Pediatric Rheumatology, Washington University School of Medicine, St Louis, Missouri, USA. baszis_k@kids.wustl.edu

Pediatrics
|December 21, 2011
PubMed

Insights

Recurrent parotitis in children may indicate primary Sjögren syndrome (SS), an autoimmune condition. Early diagnosis is crucial for effective pediatric Sjögren syndrome management and treatment.

Area of Science:

  • Pediatric Rheumatology
  • Ophthalmology
  • Immunology

Background:

  • Parotitis is common in children, often viral or bacterial.
  • Recurrent parotitis necessitates a broader differential diagnosis.
  • Primary pediatric Sjögren syndrome (SS) is a rare autoimmune cause.

Observation:

  • Four pediatric cases of isolated recurrent bilateral parotitis are presented.
  • Patients aged 9-17 years at presentation.
  • Ocular findings were present in 3/4 patients despite no subjective complaints.

Findings:

  • Laboratory results showed positive antinuclear antibody, SS A, SS B antibodies, rheumatoid factor, and hypergammaglobulinemia.
  • Pediatric SS often presents with isolated parotitis, differing from adult presentation.
  • Ophthalmologic examination revealed abnormalities in most patients.

Implications:

  • Sjögren syndrome should be considered in children with recurrent parotitis.
  • Timely diagnosis of pediatric SS enables appropriate management.
  • Understanding pediatric SS presentation is vital for pediatricians and specialists.

More Related Videos

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights07:25

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights

Published on: October 13, 2023

Related Concept Videos

Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...